In ovarian cancer, high levels of adenosine are due to tumor-specific expression of the ectonucleotidases CD39/ENTPD1 and CD73/ecto-5′-nucleotidase [7] which synergistically catalyze the degradation of extracellular immune-stimulatory ATP to immune-inhibitory adenosine. The gene discussed is ENTPD1; the disease is neoplasm.